トログリタゾンによる肝障害の機序解明への薬物動態学的アプローチ - UGTの多型は肝障害の要因となり得るか? -
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-09-17
著者
-
高崎 渉
三共(株)安全性研究所
-
真鍋 淳
三共安全性研究所
-
真鍋 淳
Laboratory Animal Science And Toxicology Laboratories Sankyo Co. Ltd.
-
池田 敏彦
三共(株)薬剤動態研究所
-
池田 敏彦
三共(株)薬物動態研究所
-
池田 敏彦
三共(株)・薬剤動態研究所
-
高崎 渉
三共・薬剤動態研
-
吉ヶ江 泰志
三共(株)・薬剤動態研究所
-
渡辺 稔之
三共(株)・安全性研究所
-
小山 久美子
三共(株)・薬剤動態研究所
-
真鍋 淳
三共(株)・安全性研究所
-
高崎 渉
三共(株)・薬剤動態研究所
-
渡辺 稔之
三共株式会社安全性研究所
関連論文
- Retroperitoneal Fibromatosis in a Cynomolgus Monkey (Macaca fascicularis)
- 医療を社会に役立てるための統計学
- Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR)
- An Attempt to Predict the Response of Human Glutathione S-Transferase (GST) to Chemical Inducers Using Transgenic Rats Harboring Human GST Gene
- CHARACTERIZATION OF RESISTANCE TO BROMOBENZENE-INDUCED HEPATOTOXICITY BY MICROARRAY
- RESISTANCE TO THE SKELETAL MUSCLE INJURY EXPRESSED BY REPEATED TREATMENT WITH COMPOUND A THAT HAS HMG-CoA REDUCTASE INHIBITORY ACTIVITY
- P7-41 Skeletal muscle injury caused by compound A completely recovers in spite of further treatment?(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- A NOVEL MODEL OF CONTINUOUS DEPLETION OF GLUTATHIONE IN MICE TREATED WITH L-BUTHIONINE (S,R)-SULFOXIMINE
- 21C-04-2 Correlation between Localization of CYP1A1/2 and Aryl Hydrocarbon Receptor in the Liver Lobule of Rats Treated with 3-methylcholantherene(3MC) or β-Naphthoflavone (BNF).
- Effects of Growth Hormone on Bone in Mini Rats
- Comparison of Bone Changes between Neonatally Monosodium Glutamate-Treated Rats and Mini Rats
- Effects of phenobarbital, a drug-metabolizing enzymes inducer, on hepatic DNA ploidy in hepatectomized rats
- Effect of Glucose Feeding on Regenerating Rat Liver Following Partial Hepatectomy
- "P-36 Hepatic response to continuous cytochrome P450 inhibition in rats sequentially treated with α-hederin.
- Relationship of induction of phase II enzymes to decrease in gap-junctional intercellular communication in rat liver treated with a disinfectant, Etridiazole.
- Correlation between decrease in intercellular communication and phase I enzyme induction in rat liver treated with phenobarbital : an examination of the reversibility during PB-withdrawal.
- DOES GLUCOSE FEEDING POTENTIATE THE TOXICITY OF HEPATOTOXICANTS?
- Induction of Glutathione S-Transferases and Hepatocellular Proliferating Activities in the Rat Liver Treated with tert-Butylated Hydroxyanisole, 1, 2-Bis(2-Pyridyl)Ethylene, and Phenobarbital
- 酵素阻害に起因する薬物相互作用のインビトロ評価 - HABプロトコール -
- サルにおける抗糖尿病薬Troglitazoneの体内動態
- 展望座談会「薬物動態学会20年の歩みと今後の展望」
- Circadian modulation of hepatic transcriptome in transgenic rats expressing human growth hormone
- アンジオテンシンII変換酵素阻害薬オルメサルタンメドキソミルのヒト血清アルブミンによる加水分解及びその触媒部位の同定(発表論文抄録(2006))
- P-183 薬物間相互作用の定量的予測を目的としたシミュレーターの作成(7.薬物相互作用(基礎と臨床)2,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- 「 臨床薬物動態試験および薬物相互ガイダンス (案) 」 開催にあたって
- 新規経口抗糖尿病薬Troglitazone立体異性体の肝臓における立体選択的代謝
- Pravastatin および Temocaprilatの肝臓移行メカニズム
- 新規抗糖尿病薬Troglitazone(CS-045)の体内動態:雌ラットにおける第一相および第二相代謝反応の逆転
- ラット及びヒト肝上清アセトイン還元酵素の解析
- トログリタゾンによる肝障害の機序解明への薬物動態学的アプローチ - UGTの多型は肝障害の要因となり得るか? -
- 薬物動態に基づく医薬品の有効性・安全性評価への道
- EFFECT OF TROGLITAZONE ON THE LIVER OF A GUNN RAT MODEL OF GENETIC ENZYME POLYMORPHISM
- Sex difference and effect of growth hormone on daily fluctuation of hepatic P450 monooxygenase activities in rats.
- Comparison of the Induction Profile of Hepatic Drug-metabolizing Enzymes Between Piperonyl Butoxide and Phenobarbital in Rats
- "B-7 Daily fluctuation of liver metabolic enzymes in F344 rats.
- "A-9 Changes of the liver and kidney in rats treated with tert-butylated hydroxyanisole (BHA).
- LOW GLUTATHIONE S-TRANSFERASE ACTIVITY IN DOG LIVER AND THE MONITORING METHOD
- SEX DIFFERENCE IN INDUCIBILITY OF LIVER DRUG METABOLIZING ENZYMES IN RATS : In particular emphasis on Phase II enzymes
- EFFECTS OF ACETONE(AT) ON HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYMES IN BEAGLE DOGS
- 168 気管支喘息患者における末梢血好酸球活性化の各評価法による検討
- 医薬品開発における臨床試験の促進と非臨床試験の役割
- 292 TXA_2 合成酵素阻害薬, CS-518のモルモット喘息モデルに対する作用 : [3] 肺気道組織におけるエイコサノイド産生に与える影響
- 抗痙縮剤CS-722の代謝研究 - ラットにおける主要代謝物とモルフォリン環の代謝を中心 -
- Collaborative work on evaluation of ovarian toxicity : 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats
- EFFECT OF DIFFERENT DOSES OF β-NAPHTHOFLAVONE(BNF) ON THE LOCALIZATION OF CYTOCHROME P-450 ISOZYMES IN THE LIVER LOBULE OF RATS
- 323 AN IMMUNOHISTOCHENICAL STUDY ON THE LOCALIZATIONS OF CHEMICAL-INDUCIBLE CYTOCHRONE P-450 WITHIN THE RAT LIVER
- 新規抗血小薬CS-747の代謝活性化機構
- 老齢B6C3F1マウスの脳小血管における自然発生鉱物質沈着症
- Love You Tender, Nancy! : バンクーバー国際会議バンケット顛末
- 肝毒性
- 医薬品開発における毒性評価のバイオマーカー
- Effects of Neonatal Administration of Monosodium Glutamate on Bone in Rats
- ラット甲状腺濾胞上皮細胞に観察された細胞質内水腫の1例(短報)
- 1, 2, 4-Triazoleの3位置換基のラットに対する甲状腺腫誘発作用の比較
- 老齢マウス視床における鉱物質沈着症のX線微小部分析
- A型MAO阻害剤RS-8359のキラルインバージョン
- HMG-CoA還元酵素阻害剤の薬物代謝酵素阻害作用
- Identification of Fatty Acid Conjugates of Plaunotol, a New Anti-ulcer Agent, Formed in Rat Liver Homogenate System
- 新規抗うつ薬RS-8359のラットおよびイヌ尿中代謝物の構造決定
- 新規2-アリルプロピオン酸系非ステロイド抗炎症薬CS-670の体内動態(1):マウス, ラットおよびイヌにおける吸収, 代謝ならびに排泄
- Stereospecific Taurine Conjugation of the trans-OH Metabolite (Active Metabolite) of CS-670,a New 2-Arylpropionic Acid Nonsteroidal Anti-inflammatory Drug, in Dogs
- プロフェン系抗炎症薬CS-670のイヌにおける立体特異的タウリン抱合
- Toxicogenomic Biomarkers for Liver Toxicity
- プロプラノロールエステル誘導体の初回代謝における肺と小腸の役割
- 肝機能障害
- プロプラノロールプロドラッグの消化管粘膜における立体選択的加水分解と粘膜透過性
- Gene expression analysis on rat livers treated with L-buthionine (S, R)-sulfoximine : investigation of data compatibility between RG U34A and RAE 230A GeneChips(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- Gene expression analysis in rat livers and immune organs treated with isoniazid, phenytoin, hydralazine hydrochloride or chlorpromazine(Proceedings of the 32nd Annual Meeting)
- P6-47 Relationship between hepatic glutathione content and gene expression profile in F344 male rats treated with L-Buthionine(S,R)-sulfoximine(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Gene expressions in F344 rat livers treated with acetaminophen or cycloheximide (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Effect of aging on gene expression profile in rat livers treated with phenobarbital or clofibrate (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Osteosarcomas in the Lungs of an ICR Mouse
- 医薬品開発における産官学人材交流のありかた(ベランダ, バイオイメージング最前線)
- 薬物毒性に関わる遺伝子変異と個人化医療 : 反応性代謝物生成から非自己認識機構まで
- 有限責任中間法人医薬品開発支援機構について
- 特異体質性の薬物毒性 : 薬物動態学的視点
- ヒト組織を利用した研究(1) : 医薬品の開発における肝組織の利用
- ライフサイエンスのためのアイソトープ測定機器(第四シリーズ) : VI. 加速器質量分析(AMS)の薬物動態試験への応用研究
- ◆◆フォーラム 1999◆◆薬物相互作用ワーキンググループ : HAB協議会データベース
- Analysis of nephropathy using DNA chip.(GENERAL SESSION BY POSTER PRESENTATION)(MOLECULAR TOXICITY & TOXICOGENOMICS)
- Gene Expression Analysis on the Rat Liver Treated with Clofibrate or Phenobarbital.(GENERAL SESSION BY POSTER PRESENTATION)(MOLECULAR TOXICITY & TOXICOGENOMICS)
- Immunohistochemical Staining Methods for Connexin32 on Formalin-Fixed Paraffin-Embedded Sections
- Biochemical and immunohistochemical studies on constitutional changes of P450 isozymes during postnatal development in rat liver.
- Pulmonary Histiocytic Sarcoma in Two Aged Dogs of a Beagle Colony
- Relationship between hepatocellular apoptosis and Kupffer cell activation in the livers of rats treated with cycloheximide(Proceedings of the 32nd Annual Meeting)
- Toxicogenoimics, Proteomics and Metabonomics(Toxicity Screening Strategy in Early Stage Drug Development : Current Situation and Perspective, Proceedings of the 32nd Annual Meeting)
- Comparison of Age-Related Bone Changes between Mini Rats and Wistar Rats
- "P-28 Study of reversibility in rat bone changes induced by beta-aminopropionitrile or aminoacetonitrile
- Effects of monosodium glutamate pretreament on the rat liver changes by clofibrate administration.
- S3-2 Risk negativeを支持するためのフォローアップ試験 : 企業の実例(シンポジウム(3)「"NEGATIVE"シンポジウム-Negative Dataの真価を問い直す」)
- 324 EFFECTS OF PHENOBARBITAL(PB) AND PARTIAL HEPATECTOMY(PH) ON HEPATIC MICROSOMAL DRUG METABOLIZING ENZYMES IN BEAGLE DOGS
- Sex and circadian modulatory effects on rat liver as assessed by transcriptome analyses
- Bronchioloalveolar Carcinoma in an Aged Beagle Dog
- ギャップ結合を介した細胞間情報伝達の阻害 : 肝腫瘍プロモーションとCYPの関連性
- Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats
- Thirteen-week Intravenous Toxicity Study of a Novel Humanized Anti-Human Death Receptor 5 Monoclonal Antibody, CS-1008, in Cynomolgus Monkeys